Means and methods for evaluating a therapy with a p38 map kinase inhibitor

Details for Australian Patent Application No. 2009290811 (hide)

Owner Universitatsklinikum Munster

Inventors Viemann, Dorothee

Agent Pizzeys

Pub. Number AU-A-2009290811

PCT Pub. Number WO2010/029167

Priority 08105324.1 12.09.08 EP; 61/108,878 28.10.08 US

Filing date 14 September 2009

Wipo publication date 18 March 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/029167 Priority application(s): WO2010/029167

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009290832-Vehicle front-end for mounting to the front face of a track-bound vehicle, in particular a rail vehicle

2009290794-Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy